Table 3. Recipients with acute rejection.

	Basiliximab (n = 78)	Steroid (n = 100)	P-value
Acute rejection	10 (12.8)	12 (12.0)	0.869†
Rejection time after transplantation
0–14 days	8 (80.0)	2 (16.7)	0.013‡
15–30 days	2 (20.0)	6 (50.0)
2–6 months	0 (0.0)	3 (25.0)
7–12 months	0 (0.0)	1 (8.3)
Revised treatment protocol
Tacrolimus	4 (40.0)	4 (33.3)	0.607‡
Glucocorticoida	3 (30.0)	6 (50.0)
MMF	1 (10.0)	0 (0.0)
Tacrolimus+glucocorticoida	1 (10.0)	0 (0.0)
Tacrolimus+MMF	1 (10.0)	2 (16.7)
Mortality, by revised treatment protocol
Tacrolimus	1 (25.0)	2 (50.0)	1.000‡
Glucocorticoida	2 (66.7)	4 (66.7)	1.000‡
MMF	0 (0.0)	–	NA
Tacrolimus+glucocorticoida	1 (100.0)	–	NA
Tacrolimus+MMF	0 (0.0)	0 (0.0)	NA

Data are presented as number (percentage).

^aGlucocorticoid treatment consisted of oral methylprednisolone or oral prednisone.

^†Chi-square test;

^‡Fisher’s exact test.

MMF = mycophenolate mofetil, NA = non-available.